Citations

Showing 10 of 108094 citations.

Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin‐mediated osteoblastogenesis
Maria, Sifat, Samsonraj, Rebekah M. , Munmun, Fahima, Glas, Jessica, Silvestros, Maria, Kotlarczyk, Mary P. , Rylands, Ryan, Dudakovic, Amel , Wijnen, André J. van , Enderby, Larry T., Lassila, Holly C. , Dodda, Bala R., Davis, Vicki L., Balk, Judy, Burow, Matt, Bunnell, Bruce A. , Witt-Enderby, Paula A , van Wijnen, Andre J , Witt‐Enderby, Paula A.

Mayo Clinic

Journal of Pineal Research | December 29, 2017 | Volume: 64 | Issue: 3 | Pages: No page available

10.1111/jpi.12465 | PMID 29285799 Get It

AbstractThe Melatonin Osteoporosis Prevention Study (MOPS) demonstrated that nightly melatonin resulted in a time‐dependent decrease in equilibrium ratios of serum osteoclasts and osteoblasts in perimenopausal women. This study examines mechanisms related to the ratios of osteoblasts and osteoclasts using coculture models (transwell or layered) of human mesenchymal stem cell (MSC) and human peripheral blood monocytes (PBMCs). Human MSC/PBMC cocultures exposed to melatonin in osteogenic (OS+) medium for 21 days induced osteoblast differentiation and mineralization; however, only in layered cocultures did melatonin inhibit osteoclastogenesis. Melatonin effects were mediated through MT2 melatonin receptors, MEK1/2, and MEK5. In layered but not transwell cocultures, melatonin increased OPG:RANKL ratios by inhibiting RANKL, suggesting that contact with osteoclasts during osteoblastogenesis inhibits RANKL secretion. Melatonin modulated expression of ERK1/2, ERK5, β1 integrin, GLUT4, and IRβ that was dependent upon the type of coculture; however, in both cultures, melatonin increased RUNX2 and decreased PPARγ expression, indicating a role for metabolic processes that control osteogenic vs adipogenic cell fates of MSCs. Furthermore, melatonin also has osteoblast‐inducing effects on human adipose‐derived MSCs. In vivo, one‐year nightly melatonin (15 mg/L) given to neu female mice in their drinking water increased pErk1/2, pErk5, Runx2, and Opg and Rankl levels in bone consistent with melatonin's already reported bone‐enhancing effects. Finally, analysis of daily logs from the MOPS demonstrated a significant improvement in mood and perhaps sleep quality in women receiving melatonin vs placebo. The osteoblast‐inducing, bone‐enhancing effects of melatonin and improvement in quality of life suggest that melatonin is a safe and effective bone loss therapy.
Pitfalls in developing precision medicine for genetic epilepsy
Shin, Cheolsu, Meador, Kimford J.

Mayo Clinic

Neurology | December 28, 2017 | Volume: 90 | Issue: 1 | Pages: 16-17

10.1212/wnl.0000000000004774 | PMID 29196575 Get It

MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification
Liu, Yu , He, Shuning , Durbin, Adam D. , Abraham, Brian J. , Easton, John , Shao, Ying , Xu, Beisi , Zhu, Shizhen , Li, Zhaodong , Weichert‐Leahey, Nina , Young, Richard A., Zhang, Jinghui , Look, A. Thomas , Zhang, Xiaoling , Xu, Beisi , Zimmerman, Mark W. , Zhang, Xiaoling , Young, Richard A

Mayo Clinic

Cancer Discovery | December 28, 2017 | Volume: 8 | Issue: 3 | Pages: 320-335

10.1158/2159-8290.cd-17-0993 | PMID 29284669 Get It

Abstract The amplified MYCN gene serves as an oncogenic driver in approximately 20% of high-risk pediatric neuroblastomas. Here, we show that the family member MYC is a potent transforming gene in a separate subset of high-risk neuroblastoma cases (∼10%), based on (i) its upregulation by focal enhancer amplification or genomic rearrangements leading to enhancer hijacking, and (ii) its ability to transform neuroblastoma precursor cells in a transgenic animal model. The aberrant regulatory elements associated with oncogenic MYC activation include focally amplified distal enhancers and translocation of highly active enhancers from other genes to within topologically associating domains containing the MYC gene locus. The clinical outcome for patients with high levels of MYC expression is virtually identical to that of patients with amplification of the MYCN gene, a known high-risk feature of this disease. Together, these findings establish MYC as a bona fide oncogene in a clinically significant group of high-risk childhood neuroblastomas. Significance: Amplification of the MYCN oncogene is a recognized hallmark of high-risk pediatric neuroblastoma. Here, we demonstrate that MYC is also activated as a potent oncogene in a distinct subset of neuroblastoma cases through either focal amplification of distal enhancers or enhancer hijacking mediated by chromosomal translocation. Cancer Discov; 8(3); 320–35. ©2017 AACR. This article is highlighted in the In This Issue feature, p. 253
Effects of Toremifene, a Selective Estrogen Receptor Modulator, on Spontaneous and Stimulated GH Secretion, IGF-I, and IGF-Binding Proteins in Healthy Elderly Subjects
Roelfsema, Ferdinand , Yang, Rebecca , Erickson, Dana , Bowers, Cyril Y., Veldhuis, Johannes D. , Yang, Rebecca J, Takahashi, Paul Y.

Mayo Clinic

Journal of the Endocrine Society | December 28, 2017 | Volume: 2 | Issue: 2 | Pages: 154-165

10.1210/js.2017-00457 | PMID 29383334 Get It

Real-Time Monitoring and Analysis of Zebrafish Electrocardiogram with Anomaly Detection
Lenning, Michael, Fortunato, Joseph, Clark, Isaac, Sherpa, Ang Samden, Yi, Soyeon, Hofsteen, Peter, Thamilarasu, Geethapriya , Yang, Jingchun , Han, Huy-Dung , Cao, Hung , Han, Huy-Dung , Le, Tai , Xu, Xiaolei , Hsiai, Tzung K.

Mayo Clinic

Sensors | December 28, 2017 | Volume: 18 | Issue: 1 | Pages: 61

10.3390/s18010061 | PMID 29283402 Get It

Heart disease is the leading cause of mortality in the U.S. with approximately 610,000 people dying every year. Effective therapies for many cardiac diseases are lacking, largely due to an incomplete understanding of their genetic basis and underlying molecular mechanisms. Zebrafish (Danio rerio) are an excellent model system for studying heart disease as they enable a forward genetic approach to tackle this unmet medical need. In recent years, our team has been employing electrocardiogram (ECG) as an efficient tool to study the zebrafish heart along with conventional approaches, such as immunohistochemistry, DNA and protein analyses. We have overcome various challenges in the small size and aquatic environment of zebrafish in order to obtain ECG signals with favorable signal-to-noise ratio (SNR), and high spatial and temporal resolution. In this paper, we highlight our recent efforts in zebrafish ECG acquisition with a cost-effective simplified microelectrode array (MEA) membrane providing multi-channel recording, a novel multi-chamber apparatus for simultaneous screening, and a LabVIEW program to facilitate recording and processing. We also demonstrate the use of machine learning-based programs to recognize specific ECG patterns, yielding promising results with our current limited amount of zebrafish data. Our solutions hold promise to carry out numerous studies of heart diseases, drug screening, stem cell-based therapy validation, and regenerative medicine.
Letter by Shiue and Sands Regarding Article, “Incorporating Nonphysician Stroke Specialists Into the Stroke Team”
Shiue, Harn , Sands, Kara, Sands, Kara A, Shiue, Harn J

Mayo Clinic

Stroke | December 28, 2017 | Volume: 49 | Issue: 2 | Pages: No page available

10.1161/strokeaha.117.019944 | PMID 29284727 Get It

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes
Swaika, Abhisek, Frank, Ryan D. , Yang, Dongyun , Finn, Laura , Jiang, Liuyan , Advani, Pooja , Chanan‐Khan, Asher , Ailawadhi, Sikander , Foran, James M. , Finn, Laura E, Chanan-Khan, Asher A., Ailawadhi, Sikander

Mayo Clinic

Cancer Medicine | December 28, 2017 | Volume: 7 | Issue: 2 | Pages: 499-507

10.1002/cam4.1266 | PMID 29282894 Get It

AbstractWe conducted a surveillance epidemiology and end results (SEER)‐based analysis to describe the incidence and characteristics of second primary acute lymphoblastic leukemia (sALL) among adults (≥18 years) with a history of primary malignancies (1M). Standardized incidence ratios (SIRs) of sALL cases were calculated by site and 1M stage. We also evaluated the differences in 5‐year sALL survival by age, site, and extent of 1M, latency of sALL after 1M, and evidence of underlying racial/ethnic disparity. We identified 10,956 patients with de‐novo/primary acute lymphoblastic leukemia (1ALL) and 772 with sALL. Women (49.1% vs. 42.9%), white patients (72.0% vs. 59.5%), older patients (58.8% vs. 25.2%; age ≥65 years), and patients diagnosed between 2003 and 2012 (66.8% vs. 53.9%) had a higher proportion of sALL compared with 1ALL. There was a significantly inferior median 5‐year survival for sALL patients compared to 1ALL (6 vs. 15 months; HR 1.20, 95% CI 1.10–1.31, P < 0.001). The median latency period was 60.0 months; the most common 1M among sALL patients were breast (17.9%) and prostate (17.4%). Patients with any 1M were at increased risk of developing sALL (SIR 1.76, 95% CI 1.58–1.95, P < 0.001). Hematological‐1M sites had significantly higher SIRs (hematological‐SIR 7.35; solid‐SIR 1.33; P < 0.001). We observed a significant increase in sALL incidence after a 1M and a significantly worse 5‐year survival with different demographic characteristics from 1ALL. There is a need to define appropriate screening methods for patients surviving their primary cancer.
How is cardiac troponin released from injured myocardium?
Mair, Johannes , Hammarsten, Ola , Huber, Kurt , Möckel, Martin , Thygesen, Kristian , Jaffe, Allan S. , Huber, Kurt , Mockel, Martin , Lindahl, Bertil , Giannitsis, Evangelos , Plebani, Mario , Jaffe, Allan S.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | December 28, 2017 | Volume: 7 | Issue: 6 | Pages: 553-560

10.1177/2048872617748553 | PMID 29278915 Get It

Cardiac troponin I and cardiac troponin T are nowadays the criterion biomarkers for the laboratory diagnosis of acute myocardial infarction due to their very high sensitivities and specificities for myocardial injury. However, still many aspects of their degradation, tissue release and elimination from the human circulation are incompletely understood. Myocardial injury may be caused by a variety of different mechanisms, for example, myocardial ischaemia, inflammatory and immunological processes, trauma, drugs and toxins, and myocardial necrosis is preceded by a substantial reversible prelethal phase. Recent experimental data in a pig model of myocardial ischaemia demonstrated cardiac troponin release into the circulation from apoptotic cardiomyocytes as an alternative explanation for clinical situations with increased cardiac troponin without any other evidence for myocardial necrosis. However, the comparably lower sensitivities of all currently available imaging modalities, including cardiac magnetic resonance imaging for the detection of particularly non-focal myocardial necrosis in patients, has to be considered for cardiac troponin test result interpretation in clinical settings without any other evidence for myocardial necrosis apart from increased cardiac troponin concentrations as well.
Adenoma and Polyp Detection Rates in Colonoscopy according to Indication
Boroff, Erika, Disbrow, Molly, Crowell, Michael D. , Ramirez, Francisco C. , Boroff, Erika S, Crowell, Michael D , Ramirez, Francisco C

Mayo Clinic

Gastroenterology Research and Practice | December 27, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-6

10.1155/2017/7207595 | PMID 29445393 Get It

Background. Adenoma detection rate (ADR) is a validated quality measure for screening colonoscopy, but there are little data for other indications. The distribution of adenomas is not well described for these indications. Aim. To describe ADR and the adenoma distribution in the proximal and distal colon based on colonoscopy indication. Methods. Outpatient colonoscopies are subdivided by indication. PDR and ADR for the entire colon and for proximal and distal colon. Data were compared using generalized estimating equations to adjust for clustering amongst endoscopists while controlling for patient age and gender. Results. 3436 colonoscopies were reviewed (51.2%: men (n=1759)). Indications are screening 49.2%, surveillance 29.3%, change in bowel habit 8.4%, bleeding 5.8%, colitides 3.0%, pain 2.8%, and miscellaneous 1.5%. Overall ADR was 37% proximal ADR 28%, and distal ADR 17%. PDR and ADR were significantly higher in surveillance than in screening (PDR: 69% versus 51%; ADR: 50% versus 33%; p=0.0001). Adenomas were more often detected in the proximal than in the distal colon, for all indications. Conclusions. Prevalence of polyps and adenomas differs based on colonoscopy indication. Adenoma detection is highest in surveillance and more commonly detected in the proximal colon. For quality assurance, distinct ADR and PDR targets may need to be established for different colonoscopy indications.